Honczarenko Marek
SEC insider (Form 3/4/5 filer). CIK 0002089105. EVP, Chief Scientific Officer at Keenova Therapeutics plc (NONE). 1 reported Form 4/5 transaction since Sep 2024; latest on Feb 25, 2026. Located in BRIDGEWATER, NJ.
Companies Honczarenko Marek has filed insider reports for
- Keenova Therapeutics plc (NONE): Officer, EVP, Chief Scientific Officer
Honczarenko Marek
CIK: 0002089105
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NONE
Keenova Therapeutics plc
Officer
Discretionary Trading P&L
Holdings
Transaction History (1 total)
- Feb 25, 2026No ticker
Keenova Therapeutics plc
AwardDirectRestricted Stock Units
58.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 25, 2026 | No ticker Keenova Therapeutics plc | Award Restricted Stock Units | 58,434 | - | - | Direct |
1-1 of 1 transactions